Table of Contents

1 Market Overview
1.1 CRISPR And CRISPR-Associated (Cas) Genes Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Caribou Biosciences
2.1.1 Business Overview
2.1.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Addgene
2.2.1 Business Overview
2.2.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 CRISPR THERAPEUTICS
2.3.1 Business Overview
2.3.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck KGaA
2.4.1 Business Overview
2.4.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mirus Bio LLC
2.5.1 Business Overview
2.5.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Editas Medicine
2.6.1 Business Overview
2.6.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Takara Bio USA
2.7.1 Business Overview
2.7.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Thermo Fisher Scientific
2.8.1 Business Overview
2.8.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Horizon Discovery Group
2.9.1 Business Overview
2.9.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Intellia Therapeutics
2.10.1 Business Overview
2.10.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 GE Healthcare Dharmacon
2.11.1 Business Overview
2.11.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global CRISPR And CRISPR-Associated (Cas) Genes Market Competition, by Manufacturer
3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Manufacturer
3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer Market Share
3.3.2 Top 6 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer Market Share
3.4 Market Competition Trend
4 Global CRISPR And CRISPR-Associated (Cas) Genes Market Analysis by Regions
4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Regions
4.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Regions (2012-2017)
4.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Regions (2012-2017)
4.2 North America CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
4.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
4.4 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
4.5 South America CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
4.6 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
5 North America CRISPR And CRISPR-Associated (Cas) Genes by Countries
5.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
5.1.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2012-2017)
5.1.2 North America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2012-2017)
5.2 USA CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
5.3 Canada CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
5.4 Mexico CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
6 Europe CRISPR And CRISPR-Associated (Cas) Genes by Countries
6.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
6.1.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2012-2017)
6.1.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2012-2017)
6.2 Germany CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
6.3 UK CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
6.4 France CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
6.5 Russia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
6.6 Italy CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
7 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes by Countries
7.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2012-2017)
7.1.2 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2012-2017)
7.2 China CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
7.3 Japan CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
7.4 Korea CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
7.5 India CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
7.6 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
8 South America CRISPR And CRISPR-Associated (Cas) Genes by Countries
8.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
8.1.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2012-2017)
8.1.2 South America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2012-2017)
8.2 Brazil CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
8.3 Argentina CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
8.4 Columbia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
9 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes by Countries
9.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2012-2017)
9.1.2 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2012-2017)
9.2 Saudi Arabia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
9.3 UAE CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
9.4 Egypt CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
9.5 Nigeria CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
9.6 South Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth (2012-2017)
10 Global CRISPR And CRISPR-Associated (Cas) Genes Market Segment by Type
10.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Type (2012-2017)
10.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2012-2017)
11 Global CRISPR And CRISPR-Associated (Cas) Genes Market Segment by Application
11.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2012-2017)
12 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
12.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Growth Rate (2017-2022)
12.2 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Regions (2017-2022)
12.2.1 North America CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
12.2.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
12.2.3 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
12.2.4 South America CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
12.2.5 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
12.3 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Type (2017-2022)
12.4 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source